Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva flags supply constraints to ADHD drug Adderall as demand rises (NYSE: TEVA) | Seeking Alpha
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Actavis CEO: Teva-Mylan deal could be "value-destroying" - Globes
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
The Difficulties of Cloning a CEO - Bloomberg
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - BNN Bloomberg
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says | Ctech
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - BNN Bloomberg
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva Generic Price-Fixing Securities Suit Gets Class Status (1)
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Israeli pharmaceutical company donating millions of doses of potential coronavirus drug to the U.S.
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
Teva CEO Rejects Netanyahu Plea to Salvage Jerusalem Plant - Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
A bottle of Teva Pharmaceutical Industries Ltd. Clonazepam medication... News Photo - Getty Images
Teva Prepared to Fight Charges in Generics Probe If Talks Fail - Bloomberg
